A pioneering drug discovery venture company promoting the development of novel cancer drugs using innovative technology.
News & Topics
- 2024.03.25
- Details of the efficacy evaluation of HM-001 will be presented in a poster presentation at the AACR Special Conference in Cancer Research: Bladder Cancer in May 2024.
- 2024.03.25
- A poster presentation on drug development utilizing MA-T system (HM-001) will be presented at AACR (American Association for Cancer Research) in April 2024.
- 2023.10.05
- We will exhibit at BioJapan2023
Corporate Philosophy
Pursuit of Innovation
Contribution to Society
Human Resource Development and Succession
Guidelines for our actions
Don't set limits for yourself
Walk one step ahead of others
Always keep efficiency in mind
Share the joy with your friends
Question your own actions once
Don't jump at the chance to innovate without getting the basics down
Act calmly and boldly
Our Thoughts
2‐2‐1, New Elimo Bid. 8F A2, Senba-nishi, Minoh-shi,
Osaka 5620036 Japan
+81-72-707-2760
401 CIMS 811-1 Kimiidera, Wakayama-shi 641-8509, Japan